Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Akumin Inc. operates a network of outpatient imaging centers across the United States, specializing in diagnostic imaging services such as MRI, CT scans, and PET scans. The company differentiates itself through strategic partnerships with healthcare providers and a focus on patient-centric care, which drives its revenue growth in a competitive healthcare landscape.
Akumin generates revenue primarily through the provision of diagnostic imaging services to patients referred by healthcare providers. The company benefits from a high volume of patient referrals and has established contracts with insurance providers, which enhances its pricing power. Its competitive advantage lies in its extensive network of imaging centers and the ability to offer specialized services that cater to regional healthcare needs.
Changes in reimbursement rates from Medicare and Medicaid
Volume of patient referrals from healthcare providers
Expansion of imaging center locations in high-demand markets
Technological advancements in imaging equipment
Regulatory changes affecting reimbursement rates for imaging services
Technological disruption from advancements in telemedicine and remote diagnostics
Increased competition from larger healthcare systems offering in-house imaging services
Emergence of new entrants in the outpatient imaging market
Negative net margin indicating potential liquidity issues
High operating losses impacting cash reserves
moderate - The demand for diagnostic imaging services is somewhat correlated with economic conditions, as consumer spending on healthcare can fluctuate with economic cycles.
Interest rates affect Akumin's financing costs for capital expenditures and could influence demand for elective imaging services as borrowing costs rise.
minimal - The company has a negative debt/equity ratio, indicating a lack of reliance on debt financing.
growth - Investors may be drawn to Akumin's rapid revenue growth and potential for market expansion.
high - The stock has shown significant price fluctuations, as evidenced by a 76.0% return over the last three months.